Modus Therapeutics Holding AB (publ)

kr 0.16As of Sun 8 Nov 2026, 12:00 UTC
STO:MODTXHealthcare
Country Sweden
PE (Fwd) •••
TSR 5Y CAGR (47.17%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.52
PE TTM —
TSR TTM (61.17%)
Mkt cap kr 23.79M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 0.194
21.43%
(70.49%)
Sell 5|0|2|3|8
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
—
—
—
—
(8.48%)
(1.95%)
9.35%
13.05%
Revenuekr M
1.573
1.621
1.619
1.677
7.39%
11.32%
6.57%
6.46%
Peers (US$2.405M)
Cap (US$)
PE
3.597M
—
2.387M
—
Capital
TTM
5Y
10Y
Leveragex
1.507
0.101
0.109
EBIT/Intx
3.521
0.191
0.196
Own earn%
(44.55)
(123.70)
(118.35)
Sh yield%
45.62
44.32
43.93
Owners
Insiders/Inst%
3.88
41.96
Short interest%
2.12
SBC / revenue%
1.45
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
18–22
$1 testx
—
Incr. ROIC%
4